期刊文献+

糖尿病性肌少症发病机制和治疗靶点的研究进展 被引量:11

Research progress on pathology mechanism and treatment target for diabetic sarcopenia
暂未订购
导出
摘要 糖尿病是一种以高血糖为特征的代谢性疾病,肌少症是其常见的慢性并发症之一。糖尿病性肌少症可能与泛素-蛋白酶体系统、胰岛素抵抗、氧化应激、线粒体损伤、胰岛素信号通路、晚期糖基化终末产物有关。本文根据国内外文献,对糖尿病性肌少症的发病机制和治疗靶点进行综述。 Diabetes is a kind of metabolic diseases characterized by hyperglycemia.Sarcopenia is one of the common diabetic complications.Development of diabetic sarcopenia is related to ubiquitin-proteasome system,insulin resistance,oxidative stress,mitochondria damage,insulin signaling pathway and advanced glycationend products.This review summarized the pathological mechanism and treatment targets for diabetic sarcopenia based on national and international literatures.
作者 丁凡 李文雄 张佳莉 张岩 DING Fan;LI Wenxiong;ZHANG Jiali;ZHANG Yan(Longhua Hospital,Shanghai University of Traditional Chinese Medicine;Key Laboratory of Theory and Therapy of Muscles and Bones,Ministry of Education,Shanghai 200032,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2019年第12期1428-1433,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金资助项目(81774329) 上海市市级医疗卫生优秀学科带头人培养计划资助(2018BR03) 上海市优秀学术带头人计划资助(19XD1423800) 科技部重大新药创制资助(2019ZX09201004-003-032) 教育部创新团队(IRT1270) 上海市自然科学基金(17ZR1430800)
关键词 糖尿病 肌少症 泛素-蛋白酶体系统 胰岛素抵抗 氧化应激 diabetes sarcopenia ubiquitin-proteasome system insulin resistance oxidative stress
  • 相关文献

参考文献3

二级参考文献21

  • 1倪晓光,赵平.泛素-蛋白酶体途径的组成和功能[J].生理科学进展,2006,37(3):255-258. 被引量:43
  • 2Smalle J,Vierstra R D. The ubiquitin 26S proteasome proteolytic pathway[J].Annual Review of Plant Biology,2004.555-590.
  • 3Glickman M H,Ciechanover A. The ubiquitin-proteasome proteolytic pathway:destruction for the sake of construction[J].Physiological Reviews,2002,(02):373-428.
  • 4Cong H,Sun L,Liu C. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered shRNAs attenuates muscle atrophy in fasting mice[J].Human Gene Therapy,2011,(03):313-324.
  • 5Gennaro G,De Rosa R,Piscione F. Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure[J].European Journal of Heart Failure,2010,(12):1290-1296.
  • 6Frost R A,Nystrom G J,Jefferson L S. Hormone,cytokine,and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle[J].American Journal of Physiology Endocrinology and Metabolism,2007,(02):E501-E512.
  • 7Nystrom G,Pruznak A,Huber D. Local insulin-like growth factor I prevents sepsis-induced muscle atrophy[J].Metabolism-Clinical and Experimental,2009,(06):787-797.
  • 8Muscaritoli M,Bossola M,Aversa Z. Prevention and treatment of cancer cachexia:new insights into an old problem[J].European Journal of Cancer,2006,(01):31-41.
  • 9Bossola M,Muscaritoli M,Costelli P. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients[J].Annals of Surgery,2003,(03):384-389.
  • 10Costelli P,Muscaritoli M,Bossola M. IGF-1 is downregulated in experimental cancer cachexia[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2006,(03):R674-R683.

共引文献60

同被引文献119

引证文献11

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部